Karim Mrouj

1.0k total citations
5 papers, 366 citations indexed

About

Karim Mrouj is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karim Mrouj has authored 5 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karim Mrouj's work include Adenosine and Purinergic Signaling (2 papers), Cancer-related Molecular Pathways (2 papers) and Nuclear Receptors and Signaling (2 papers). Karim Mrouj is often cited by papers focused on Adenosine and Purinergic Signaling (2 papers), Cancer-related Molecular Pathways (2 papers) and Nuclear Receptors and Signaling (2 papers). Karim Mrouj collaborates with scholars based in France, United States and Croatia. Karim Mrouj's co-authors include Daniel Fisher, Liliana Krasińska, Michal Sobecki, Vjekoslav Dulić, Jacques Colinge, François Gerbe, Philippe Jay, Priyanka Singh, Geronimo Dubra and Florence Bernex and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Cell Science.

In The Last Decade

Karim Mrouj

4 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karim Mrouj France	3	173	102	70	59	34	5	366
Sampa Ghose India	12	185 1.1×	67 0.7×	99 1.4×	52 0.9×	40 1.2×	20	344
Durga Attili United States	11	199 1.2×	111 1.1×	111 1.6×	88 1.5×	23 0.7×	16	436
Jade Peres South Africa	13	308 1.8×	112 1.1×	104 1.5×	61 1.0×	44 1.3×	20	456
Vui King Vincent–Chong Malaysia	15	243 1.4×	117 1.1×	124 1.8×	74 1.3×	21 0.6×	30	484
Xiaodong Lyu China	9	163 0.9×	180 1.8×	85 1.2×	36 0.6×	24 0.7×	24	428
Zhefeng Zhao China	12	297 1.7×	126 1.2×	52 0.7×	96 1.6×	34 1.0×	16	471
Jiantao Xiao China	12	221 1.3×	66 0.6×	72 1.0×	69 1.2×	74 2.2×	16	367
Shruti Pandita United States	10	349 2.0×	97 1.0×	60 0.9×	35 0.6×	19 0.6×	16	512
Alexander Hamm Germany	5	209 1.2×	116 1.1×	91 1.3×	44 0.7×	28 0.8×	9	385

Countries citing papers authored by Karim Mrouj

Since Specialization

Citations

This map shows the geographic impact of Karim Mrouj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Mrouj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Mrouj more than expected).

Fields of papers citing papers by Karim Mrouj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Mrouj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Mrouj. The network helps show where Karim Mrouj may publish in the future.

Co-authorship network of co-authors of Karim Mrouj

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Mrouj. A scholar is included among the top collaborators of Karim Mrouj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Mrouj. Karim Mrouj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kim, Ji Yun, José Luís Braga de Aquino, Chunyou Mao, et al.. (2024). 52 The adenosine receptor antagonist etrumadenant reduces tumor adenosine-regulated NR4A gene expression and increases mCRC inflammation in patients from the ARC-9 trial. Regular and Young Investigator Award Abstracts. A58–A58.

2.

Kim, Ji Yun, Ning Wang, Benjamin R. Weeder, et al.. (2024). Abstract C007: Quemliclustat (CD73 Inhibitor) reduces adenosine-regulated NR4A gene expression and increases mPDAC inflammation in patients from the ARC-8 trial. Cancer Research. 84(17_Supplement_2). C007–C007. 1 indexed citations

3.

Lossaint, Gérald, Véronique Gire, Karim Mrouj, et al.. (2022). Reciprocal regulation of p21 and Chk1 controls the cyclin D1-RB pathway to mediate senescence onset after G2 arrest. Journal of Cell Science. 135(8). 26 indexed citations

4.

Mrouj, Karim, Geronimo Dubra, Priyanka Singh, et al.. (2021). Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proceedings of the National Academy of Sciences. 118(10). 74 indexed citations

5.

Sobecki, Michal, Karim Mrouj, Jacques Colinge, et al.. (2017). Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels. Cancer Research. 77(10). 2722–2734. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact